ERG and prostate neoplasm: It was also recently determined that ERG (and the common TMPRSS2–ERG fusion) activates the transcriptional program regulated by YAP1, and that prostate-specific activation of either ERG or YAP1 in mice induces similar transcriptional changes and results in age-related prostate tumors [29].